Updates in the treatment of moderate to severe atopic dermatitis: A focus on JAK inhibitors Miscellaneous
| Authors: | Eng, S.; Vadakkel, G.; DeMatteo, R. |
| Title: | Updates in the treatment of moderate to severe atopic dermatitis: A focus on JAK inhibitors |
| Keywords: | signal transduction; gene mutation; janus kinase inhibitor; drug efficacy; drug withdrawal; ultraviolet radiation; quality of life; mitogen activated protein kinase p38; nausea; interleukin 13; inflammation; genetic variation; creatinine; pruritus; disease severity; immune response; acne; patient safety; recurrent disease; creatine kinase; emollient agent; dermatitis; headache; interleukin 17; corticosteroid; upper respiratory tract infection; rhinopharyngitis; pimecrolimus; randomized controlled trial (topic); phase 2 clinical trial (topic); light exposure; phase 3 clinical trial (topic); calcineurin; atopic dermatitis; application site reaction; ruxolitinib; eczema; article; numeric rating scale; environmental risk; upadacitinib; abrocitinib; filaggrin; eczema area and severity index |
| Journal Title: | Pharmacy Times |
| Volume: | 90 |
| Issue: | 11 |
| ISSN: | 0003-0627 |
| Publisher: | Intellisphere, LLC |
| Date Published: | 2024-11-01 |
| Start Page: | 32 |
| End Page: | 33 |
| Language: | English |
| PROVIDER: | scopus |
| DOI/URL: | |
| Notes: | Trade publication -- Source: Scopus |
